- Home
- FATE vs GMGI Comparison
FATE vs GMGI Comparison
Compare FATE & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FATE | GMGI |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.8M | 115.8M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | FATE | GMGI |
|---|---|---|
| Price | $1.07 | $0.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $3.92 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.5M | 225.9K |
| Earning Date | 11-13-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,137,000.00 | ★ $179,142,103.00 |
| Revenue This Year | N/A | $25.59 |
| Revenue Next Year | N/A | $14.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 37.24 |
| 52 Week Low | $0.66 | $0.66 |
| 52 Week High | $1.94 | $2.60 |
Technical Indicators
Market Signals| Indicator | FATE | GMGI |
|---|---|---|
| Relative Strength Index (RSI) | 51.95 | 27.86 |
| Support Level | $0.97 | $0.80 |
| Resistance Level | $1.13 | $0.82 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 63.69 | 4.91 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.